OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 543 shares of the medical equipment provider’s stock, valued at approximately $283,000.
Several other institutional investors also recently added to or reduced their stakes in the stock. Xponance Inc. lifted its holdings in shares of Intuitive Surgical by 2.5% in the fourth quarter. Xponance Inc. now owns 82,327 shares of the medical equipment provider’s stock worth $42,971,000 after buying an additional 1,982 shares in the last quarter. Intech Investment Management LLC lifted its holdings in shares of Intuitive Surgical by 47.5% in the fourth quarter. Intech Investment Management LLC now owns 38,859 shares of the medical equipment provider’s stock worth $20,283,000 after buying an additional 12,513 shares in the last quarter. Generali Asset Management SPA SGR purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $12,942,000. Evoke Wealth LLC lifted its holdings in shares of Intuitive Surgical by 40.4% in the fourth quarter. Evoke Wealth LLC now owns 1,087 shares of the medical equipment provider’s stock worth $567,000 after buying an additional 313 shares in the last quarter. Finally, Horizon Investments LLC lifted its holdings in shares of Intuitive Surgical by 32.5% in the fourth quarter. Horizon Investments LLC now owns 11,884 shares of the medical equipment provider’s stock worth $6,203,000 after buying an additional 2,916 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Finally, Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.
Insider Transactions at Intuitive Surgical
In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock opened at $491.81 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market capitalization of $175.17 billion, a price-to-earnings ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s 50 day moving average price is $563.34 and its 200-day moving average price is $531.34.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Comparing and Trading High PE Ratio Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How to Use the MarketBeat Stock Screener
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.